Addition of angiotensin receptor blockade to ACE inhibition versus high dose ACE inhibition for reduction of proteinuria in patients with diabetic nephropathy.
Phase of Trial: Phase II
Latest Information Update: 13 Oct 2009
At a glance
- Drugs Irbesartan (Primary) ; Trandolapril
- Indications Diabetic nephropathies; Proteinuria
- Focus Therapeutic Use
- 25 Jul 2007 Status changed from recruiting to completed.
- 13 Jul 2007 New trial record.